BioGenex® Influenza SARS-CoV-2 (Flu SC2) Multiplex RT-PCR Assay (RUO)

  • Influenza SARS-CoV-2 (Flu SC2) Multiplex RT-PCR Assay is a molecular in vitro test that aids in the detection and differentiation of influenza A virus, influenza B virus or/and SARS-CoV-2 and is based on widely used nucleic acid amplification technology.
  • In this test, three primer and probe sets aid to detect one specific regions of the Influenza A {Matrix, (M1) gene}, Influenza B {Nonstructural 2 (NS2) gene}, and Covid-19 (N gene) and one primer and probe set to detect human RNase P in a test sample.
  • Specific: Detection and differentiation of RNA from influenza A virus, influenza B virus or/and SARS-CoV-2.
  • Sensitive: Limit of detection (LoD)of 25 copies/uL.
  • Flexible: Compatible with a variety of sample types.
  • Reliable: Performance confirmed and verified with case studies from outbreak’s point of origin.
  • Gold standard protocol as recommended by CDC.
  • Gives medical practitioners right information to control the spread of COVID-19 and Flu.
  • Allows for on-going flu surveillance while also testing for SARS-CoV-2.
  • Process more tests in a given period of time and conserves important testing materials that are in short supply.
Clear